BioCryst Pharmaceuticals
BCRX
#4481
Rank
C$3.29 B
Marketcap
C$13.12
Share price
1.25%
Change (1 day)
34.08%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): C$0.36 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are C$0.87 Billion. , an increase over its 2024 earnings that were of -C$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 C$0.36 B-407.51%
2024 -C$0.12 Billion-61.56%
2023 -C$0.32 Billion-7.43%
2022 -C$0.34 Billion34.42%
2021 -C$0.26 Billion-0.55%
2020 -C$0.26 Billion67.88%
2019 -C$0.15 Billion7.55%
2018 -C$0.14 Billion53.92%
2017 -C$90.53 Million19.29%
2016 -C$75.89 Million28.19%
2015 -C$59.2 Million-4.8%
2014 -C$62.19 Million50.09%
2013 -C$41.44 Million-23.29%
2012 -C$54.02 Million-26.19%
2011 -C$73.18 Million54.78%
2010 -C$47.28 Million150.1%
2009 -C$18.91 Million-49.43%
2008 -C$37.39 Million14.07%
2007 -C$32.77 Million-49.31%
2006 -C$64.65 Million72.87%
2005 -C$37.4 Million22.08%
2004 -C$30.64 Million75.3%
2003 -C$17.48 Million-25.36%
2002 -C$23.42 Million225.05%
2001 -C$7.21 Million-56.6%
2000 -C$16.6 Million50.63%
1999 -C$11.02 Million38.05%
1998 -C$7.99 Million-52.46%
1997 -C$16.79 Million58.44%
1996 -C$10.6 Million-14.44%
1995 -C$12.39 Million28.57%
1994 -C$9.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$13.48 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.61 B 3,600.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-C$0.35 Billion-194.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$0.11 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$0.51 B 40.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.4 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-C$11.19 Million-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$34.08 Million-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA